SEC Form 4 · accession 0001144204-17-026071
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zhijing Cbpo Liu
Officer — Corporate Vice President
Period of report
May 8, 2017
Accepted (ET)
May 10, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 8, 2017 | M | 6,358 | $9.85 | A | 10,969 | D | |
| Common StockF2,F5 | May 8, 2017 | S | 6,358 | $116.68 | D | 4,611 | D | |
| Common StockF3 | May 9, 2017 | M | 1,142 | $9.85 | A | 5,753 | D | |
| Common StockF4,F6 | May 9, 2017 | S | 1,142 | $115.40 | D | 4,611 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F7 | $9.85 | May 8, 2017 | M | 6,358 | D | Sep 1, 2016 | Aug 31, 2022 | Common Stock | 6,358 | 1,142 | D |
| Stock Option (right to buy)F7 | $9.85 | May 9, 2017 | M | 1,142 | D | Sep 1, 2016 | Aug 31, 2022 | Common Stock | 1,142 | 0 | D |
Explanation of responses
- F1Represents 6,358 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
- F2Represents 6,358 shares of common stock sold on the open market at a weighted average price of $116.68 per share on May 8, 2017.
- F3Represents 1,142 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
- F4Represents 1,142 shares of common stock sold on the open market at a weighted average price of $115.40 per share on May 9, 2017.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $116.62 to $116.95, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 5.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $115.20 to $115.65, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 6.
- F7Represents previously reported stock options to purchase 15,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were vested annually over a 4-year period in four equal portions, with the initial vesting date being September 1, 2013.